TY  - GEN
AU  - Scott,Bart L
AU  - Pasquini,Marcelo C
AU  - Logan,Brent R
AU  - Wu,Juan
AU  - Devine,Steven M
AU  - Porter,David L
AU  - Maziarz,Richard T
AU  - Warlick,Erica D
AU  - Fernandez,Hugo F
AU  - Alyea,Edwin P
AU  - Hamadani,Mehdi
AU  - Bashey,Asad
AU  - Giralt,Sergio
AU  - Geller,Nancy L
AU  - Leifer,Eric
AU  - Le-Rademacher,Jennifer
AU  - Mendizabal,Adam M
AU  - Horowitz,Mary M
AU  - Deeg,H Joachim
AU  - Horwitz,Mitchell E
TI  - Myeloablative Versus Reduced-Intensity Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndromes
SN  - 1527-7755
PY  - 2017///0728
KW  - Adult
KW  - Aged
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - therapeutic use
KW  - Busulfan
KW  - administration & dosage
KW  - Cause of Death
KW  - Cyclosporine
KW  - Disease-Free Survival
KW  - Female
KW  - Graft vs Host Disease
KW  - etiology
KW  - Hematopoietic Stem Cell Transplantation
KW  - adverse effects
KW  - Humans
KW  - Immunosuppressive Agents
KW  - Kaplan-Meier Estimate
KW  - Leukemia, Myeloid, Acute
KW  - therapy
KW  - Male
KW  - Melphalan
KW  - Middle Aged
KW  - Myelodysplastic Syndromes
KW  - Recurrence
KW  - Survival Rate
KW  - Transplantation Conditioning
KW  - Transplantation, Homologous
KW  - Vidarabine
KW  - Whole-Body Irradiation
KW  - Young Adult
N1  - Publication Type: Clinical Trial, Phase III; Comparative Study; Journal Article; Randomized Controlled Trial
UR  - https://doi.org/10.1200/JCO.2016.70.7091
ER  -